<DOC>
	<DOCNO>NCT01269788</DOCNO>
	<brief_summary>Gastro-esophageal reflux disease ( GERD ) highly prevalent , affect 20 % adult population North America . Up 70 % GERD patient non-erosive reflux disease ( NERD ) , term use describe symptom suggestive GERD patient endoscopic evidence erosive esophagitis . NERD represent heterogeneous group patient sub classify accord 24 hours-PH monitoring result also symptom-acid association analysis ( Symptom Index , SI ) . Treatment NERD challenge clinician . According many study , pool rate symptomatic response period proton pomp inhibitor ( PPIs ) therapy frequently use drug , NERD patient lower erosive esophagitis patient . It also show acid exposure much low NERD patient erosive esophagitis NERD patient less likely exhibit strong association heartburn symptom acid reflux event patient erosive oesophagitis . Furthermore , beside high economic burden , concern adverse effect long time administration PPIs . Several hypothesis propose describe low response rate NERD patient PPIs . One acceptable theory patient anxiety depression psychological problem increase risk develop reflux symptom . On hand , pain modulators sertraline , selective serotonin reuptake inhibitor ( SSRI ) , antidepressant show improve symptom patient functional gastrointestinal disorder like non cardiac chest pain . According above-mentioned tip , investigator hypothesize antidepressant like fluoxetine , SSRI , may beneficial effect improve symptom NERD patient . The purpose study compare effect omeprazole fluoxetine placebo treatment NERD patient subgroups experience reflux symptom normal endoscopic finding .</brief_summary>
	<brief_title>Comparing Omeprazole With Fluoxetine Treatment Non Erosive Reflux Disease Its Subgroups : Double-blind Placebo-controlled Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Antidepressive Agents , Second-Generation</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>age 18 60 year old experience heartburn last 6 month inclusion experience heartburn least 4 7 day inclusion presence normal mucosa upper gastrointestinal ( GI ) endoscopy document 7 day inclusion provide patient administer PPI last 30 day inclusion inability undergone upper GI endoscopy PH monitoring presence barret 's esophagus erosive esophagitis upper GI endoscopy presence active peptic ulcer disease disease affect absorption drug inflammatory bowel disease past history esophageal gastric surgery esophageal stricture need dilation administration proton pomp inhibitor 30 day inclusion study administration H2 blocker , anticholinergic , sucralfate prokinetics assessment eligibility also study long time administration nonsteroidal antiinflammatory drug ( NSAIDs ) administration neuroleptic antidepressant drug 30 day inclusion study know allergy PPIs SSRIs presence significant systemic disease scleroderma , diabet mellitus , peripheral autonomic neuropathy ... pregnancy female presence know psychiatric disorder depression , panic disorder drug addiction accord DSMIV criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>non-erosive reflux disease</keyword>
	<keyword>heartburn</keyword>
	<keyword>functional</keyword>
	<keyword>Antidepressive Agents , Second-Generation</keyword>
	<keyword>Proton Pump Inhibitors</keyword>
</DOC>